While price cut cards can assist ease the burden of higher drug costs in the short-term, they do not tackle the systemic concerns driving up prescription charges inside the U.S. Broader policy changes could deal with the root causes of growing drug costs, like not enough transparency in pricing and the part of intermediaries like PBMs.Goods conform